BioStock: PHI links up with two regenerative medicine networks

September 7, 2023
Language flag

In 2023, Phase Holographic Imaging has solidified its footprint in regenerative medicine. While the summer appeared calm on the surface, behind-the-scenes activities have been brewing. Most notably, the company has been actively expanding its regenerative medicine network through two strategic organization memberships. CEO Patrik Eschricht tells us more in this BioStock interview.

Read the full interview with Patrik Eschricht on biostock.se.

Latest News

Directed issue registered at the Companies Registration Office

PHI Board of Directors’ proposal on a directed issue to Altium S.A. was resolved on the extraordinary general meeting on November 15, 2023. The directed issue has now been registered at the Swedish Companies Registration Office.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 15 november 2023

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on November 15, 2023. The following resolutions were passed at the meeting.
BioStock-PHI-CEO-reflects-on-the-company-momentum

BioStock: PHI’s CEO reflects on the Company’s momentum

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
See All News